Cargando…

Heterogeneity of Glycan Biomarker Clusters as an Indicator of Recurrence in Pancreatic Cancer

Mostrar otras versiones (1)

Outcomes following tumor resection vary dramatically among patients with pancreatic cancer. A challenge in defining predictive biomarkers is to discern within the complex tumor tissue the specific subpopulations and relationships that drive recurrence. Multiplexed immunofluorescence is valuable for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wisniewski, Luke, Braak, Samuel, Klamer, Zachary, Gao, ChongFeng, Shi, Chanjuan, Allen, Peter, Haab, Brian B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881915/ https://www.ncbi.nlm.nih.gov/pubmed/36711795 http://dx.doi.org/10.1101/2023.01.05.522607

Ejemplares similares

Heterogeneity of glycan biomarker clusters as an indicator of recurrence in pancreatic cancer
por: Wisniewski, Luke, et al.
Publicado: (2023)

Advances in Tools to Determine the Glycan-Binding Specificities of Lectins and Antibodies
por: Haab, Brian B., et al.
Publicado: (2020)

Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen–Defined Pancreatic Cancer Tissues
por: McDowell, Colin T., et al.
Publicado: (2020)

Deciphering Protein Glycosylation by Computational Integration of On-chip Profiling, Glycan-array Data, and Mass Spectrometry
por: Klamer, Zachary, et al.
Publicado: (2019)

CarboGrove: a resource of glycan-binding specificities through analyzed glycan-array datasets from all platforms
por: Klamer, Zachary L, et al.
Publicado: (2022)

Bioorthogonal Chemical Labeling Probes Targeting Sialic Acid Isomers for N-Glycan MALDI Imaging Mass Spectrometry of Tissues, Cells, and Biofluids
por: Lu, Xiaowei, et al.
Publicado: (2023)

Mining High-Complexity Motifs in Glycans: A New Language To Uncover the Fine Specificities of Lectins and Glycosidases
por: Klamer, Zachary, et al.
Publicado: (2017)

Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9
por: Tang, Huiyuan, et al.
Publicado: (2015)

Conformational Heterogeneity of the HIV Envelope Glycan Shield
por: Yang, Mingjun, et al.
Publicado: (2017)

Glycans as Biomarkers in Prostate Cancer
por: Scott, Emma, et al.
Publicado: (2019)

Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization
por: Ringe, Rajesh P., et al.
Publicado: (2023)

Structural Heterogeneity of Terminal Glycans in Campylobacter jejuni Lipooligosaccharides
por: Semchenko, Evgeny A., et al.
Publicado: (2012)

Glycan Analysis as Biomarkers for Testicular Cancer
por: Hires, Michal, et al.
Publicado: (2019)

Developments in the Identification of Glycan Biomarkers for the Detection of Cancer
por: Ruhaak, L. Renee, et al.
Publicado: (2013)

Discovery of N-glycan Biomarkers for the Canine Osteoarthritis
por: Lee, Hyunjun, et al.
Publicado: (2020)

Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present
por: Stevenson-Leggett, Phoebe, et al.
Publicado: (2021)

MALDI Imaging Mass Spectrometry Profiling of N-Glycans in Formalin-Fixed Paraffin Embedded Clinical Tissue Blocks and Tissue Microarrays
por: Powers, Thomas W., et al.
Publicado: (2014)

Glycans Are a Novel Biomarker of Chronological and Biological Ages
por: Krištić, Jasminka, et al.
Publicado: (2014)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Protein Secondary Structure Affects Glycan Clustering in Native Mass Spectrometry
por: Yan, Hao, et al.
Publicado: (2021)

Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers
por: Gebrehiwot, Abrha G., et al.
Publicado: (2018)

Cell-based glycan arrays for probing glycan–glycan binding protein interactions
por: Briard, Jennie Grace, et al.
Publicado: (2018)

Lectin‐based phototherapy targeting cell surface glycans for pancreatic cancer
por: Kuroda, Yukihito, et al.
Publicado: (2022)

Heterogeneity in glycan composition on the surface of HIV-1 envelope determines virus sensitivity to lectins
por: Jan, Muzafar, et al.
Publicado: (2018)

Fucosylated N-glycans as early biomarkers of COVID-19 severity
por: Paton, Beatrix, et al.
Publicado: (2023)

Back pain as a potential indicator of local recurrence in pancreatic cancer
por: Tieftrunk, Elke, et al.
Publicado: (2015)

Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
por: Watanabe, Yasunori, et al.
Publicado: (2020)

Glycan profiling of the gut microbiota by Glycan-seq
por: Oinam, Lalhaba, et al.
Publicado: (2022)

Pancreatic Fibroblast Heterogeneity: From Development to Cancer
por: Garcia, Paloma E., et al.
Publicado: (2020)

So You Discovered a Potential Glycan-Based Biomarker; Now What? We Developed a High-Throughput Method for Quantitative Clinical Glycan Biomarker Validation
por: Shipman, Joshua T., et al.
Publicado: (2020)

Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer
por: Hoffmann, Oliver Ingo, et al.
Publicado: (2022)

Glycan heterogeneity on gold nanoparticles increases lectin discrimination capacity in label-free multiplexed bioassays†
por: Otten, Lucienne, et al.
Publicado: (2016)

A proposal: That the heterogeneity of glycoprotein N-glycans is a feature of their biosynthesis and may be of functional significance
por: März, L., et al.
Publicado: (1984)

Characterization of Monoclonal Antibody Glycan Heterogeneity Using Hydrophilic Interaction Liquid Chromatography-Mass Spectrometry
por: Singh, Sumit K., et al.
Publicado: (2022)

Homo- and Heterogeneous Glycoconjugates on the Basis of N-Glycans and Human Serum Albumin: Synthesis and Biological Evaluation
por: Kurbangalieva, Almira, et al.
Publicado: (2022)

The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer
por: Liu, Long, et al.
Publicado: (2013)

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events
por: Akinkuolie, Akintunde O., et al.
Publicado: (2014)

Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers?
por: DellaValle, Brian, et al.
Publicado: (2018)

Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer
por: Qin, Ruihuan, et al.
Publicado: (2017)

IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers
por: Haslund-Gourley, Benjamin S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bn1mcmjvt1mg6cqmjjc52jq3h1